Skip to main content
Equibles
BOLD logo

BOLD · Boundless Bio, Inc. · Financials

Track BOLD — free

Use BOLD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BOLD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.83 -0.01 (-0.35%) At close · Sep 11
Rebalance outlook locked
Market Cap
$64.38M
Shares
22.75M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Net Income
-$58.2M +11%
FY2025 Net Income FY2023–FY2025
Diluted EPS
-$2.60 +32.5%
FY2025 Diluted EPS FY2023–FY2025
Operating Cash Flow
-$46.66M +23.3%
FY2025 Operating Cash Flow FY2023–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2025 FY2024 FY2023
$44.2M $44.85M $55.27M $42.64M
$23.81M $18.71M $18M $12.16M
$2.22M $1.25M $1.09M $957K
$68.01M $63.55M $73.27M $54.8M
-$68.01M -$63.55M -$73.27M -$54.8M
$4M $5.36M $7.89M $5.28M
$4M $5.36M $7.9M $5.36M
— $0 $0 —
-$64.01M -$58.2M -$65.36M -$49.43M
-$64.04M -$58.25M -$65.28M -$49M
USD/shares -$2.85 -$2.60 -$3.85 -$40.65
USD/shares -$2.85 -$2.60 -$3.85 -$40.65
shares — 22.36M 16.98M 1.22M
shares — 22.36M 16.98M 1.22M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 5.50×
EV/EBIT
—
Peer median 12.38×
P/E (TTM)
—
Peer median 4.06×

Peer medians compare against the 293 similar-size Biotechnology companies (of 536 listed).

Key facts CIK 1782303 CUSIP 10170A100 13F (30d) 30 filings 30 filers Visit website Investor relations